Skip to main content
Clinical Trials/NCT05134090
NCT05134090CompletedNot Applicable

Percutaneous Laparoscopy for Ovarian Tissue Cryopreservation: a Single-center Experience.

Regina Elena Cancer Institute1 site in 1 country59 target enrollmentStarted: May 10, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
59
Locations
1
Primary Endpoint
Aesthetic outcomes

Study Overview

Brief Summary

To compare surgical outcomes of oncologic patients that underwent conventional laparoscopy and percutaneous laparoscopy for cryopreservation of ovarian tissue.

Detailed Description

This is a retrospective analysis to evaluate the efficacy and safety of percutaneous laparoscopy for the ovarian tissue explant in oncologic women. Surgical outcomes of patients that underwent percutaneous laparoscopy were compared with those of women that underwent conventional laparoscopy. Data from 2017 to 2021 were collected in a single Oncologic Center in Italy. The principal outcomes considered are post-operative pain, recovery time and aesthetic outcomes.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to 42 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Oncologic women with desire to preserve fertility

Exclusion Criteria

  • Ovarian explant with different techniques than laparoscopy

Outcomes

Primary Outcomes

Aesthetic outcomes

Time Frame: minimum 3 months after surgery

General satisfaction regarding aesthetic outcomes is collected with a satisfaction survey. The score ranged from 1 to 5, with 1 indicating "very dissatisfied" and 5 "very satisfied".

Post-operative pain

Time Frame: 0-1 and 2 days after surgery

Post-operative pain is evaluated with VAS score ranging from 1 to 10 (higher score, maximum pain)

Secondary Outcomes

  • Blood loss(1 day)
  • Recovery time(Days)
  • Surgical complications(30 days)
  • Operative time(1 day)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Benito Chiofalo

Principal Investigator

Regina Elena Cancer Institute

Study Sites (1)

Loading locations...

Similar Trials